Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1.
about
Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription.The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNAThe Host RNAs in Retroviral ParticlesHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchHost RNA Packaging by Retroviruses: A Newly Synthesized StoryExploiting tRNAs to Boost VirulencePrimer tRNAs for reverse transcriptionInability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.The nucleocapsid protein specifically anneals tRNALys-3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro.Vpr-host interactions during HIV-1 viral life cycle.Maintenance of the Gag/Gag-Pol ratio is important for human immunodeficiency virus type 1 RNA dimerization and viral infectivity.Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic.Effect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity.Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs.The role of A-kinase anchoring protein 95-like protein in annealing of tRNALys3 to HIV-1 RNA.Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex.Rapid localization of Gag/GagPol complexes to detergent-resistant membrane during the assembly of human immunodeficiency virus type 1.HIV-1 modulates the tRNA pool to improve translation efficiency.Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly.Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse transcription.The allosteric HIV-1 integrase inhibitor BI-D affects virion maturation but does not influence packaging of a functional RNA genomeEffects of modifying the tRNA(3Lys) anticodon on the initiation of human immunodeficiency virus type 1 reverse transcriptionAtomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes.Incorporation of pol into human immunodeficiency virus type 1 Gag virus-like particles occurs independently of the upstream Gag domain in Gag-polNew insights into inhibition of human immunodeficiency virus type 1 replication through mutant tRNALys3.Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.Small-angle X-ray scattering-derived structure of the HIV-1 5' UTR reveals 3D tRNA mimicry.Formation of the tRNALys packaging complex in HIV-1.Frequent dual initiation in human immunodeficiency virus-based vectors containing two primer-binding sites: a quantitative in vivo assay for function of initiation complexes.Initiation of HIV Reverse TranscriptionAnalysis of the human immunodeficiency virus-1 RNA packageome.The role of nucleocapsid and U5 stem/A-rich loop sequences in tRNA(3Lys) genomic placement and initiation of reverse transcription in human immunodeficiency virus type 1.Role of RNA in facilitating Gag/Gag-Pol interaction.Roles of Gag and NCp7 in facilitating tRNA(Lys)(3) Annealing to viral RNA in human immunodeficiency virus type 1Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1.Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1.Conservation of tRNA mimicry in the 5'-untranslated region of distinct HIV-1 subtypes.Ability of wild-type and mutant lysyl-tRNA synthetase to facilitate tRNA(Lys) incorporation into human immunodeficiency virus type 1.Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.Switching the in vitro tRNA usage of HIV-1 by simultaneous adaptation of the PBS and PAS.
P2860
Q24523263-E08BE160-5A3C-4C98-920C-7274B91DCE40Q24806162-8EABF49A-6CF4-412A-B124-A8DCECA6864BQ26739938-4B1B3A10-749C-49D8-9FA6-2103C76B47A8Q26746070-502DB6FB-30FB-4A7B-8C9E-F008F12F70CAQ26767304-573BA2BF-4022-4270-B80E-7951C8EFE3E1Q26770055-E0D86BCB-E146-4DE2-A3F0-9142FDEF5C2FQ28775697-DCB15826-473F-4D6E-8439-8BE41A516254Q30439541-B197EA79-EA44-4470-BF9F-8293E7A3A6E7Q33709362-862E8E5A-EA23-40AB-BA29-A33FFDE49B4AQ33828332-8D4BBC4F-7862-44E0-8A9F-C8E27988A975Q33837707-A59B1A5A-AEC5-480D-BD22-F4BBC3515030Q33962718-7527E165-7717-400E-8C7C-1913D6258857Q34344599-57AACE9E-C424-4EC8-A758-FD0003E9F0BBQ34353288-341D8902-FCCC-4C41-9633-E8AC0B452373Q34468488-5A3A5E0F-4709-4F96-B2F8-FBF31494BC41Q34658242-1218D06F-4078-4D68-84FF-D6F3C61A2CF8Q34781698-28C8712A-F682-4B2B-88FF-92C88C469F21Q34994062-97CAD783-EDAD-40AF-800D-AF541D972966Q35123403-6934BD42-415B-4541-BFDD-A51C18D23A36Q35149625-2DB5C9FC-A8EF-483B-8FF7-66C222C8FBF5Q35215018-7C3F5584-ECCA-4EA6-82FB-01815AE55630Q35864780-90BB8F47-0EC4-4233-B73B-F458399CDA5CQ36890537-A2C8D6CF-CD49-47F0-B40F-BEAA1B537BF1Q36942505-34B9D1E9-45D6-4CF6-8B8B-820B3E519C70Q37320502-9B668A7A-99B1-4365-9D26-A286958C408EQ37568313-DE3D6DB8-97F8-4BFB-8849-EF821972AA0DQ37628044-9AF59C32-02B9-4156-A561-365F9BDE1F8CQ37633035-9EDFC966-870A-4D4D-BB61-36D77C7A8B1EQ37730594-1AA211C5-71FF-4FC2-8960-C59B92CEBFFFQ38613919-13991FC7-0A35-42A1-B433-A43B48AB72F9Q38767206-D71860B5-0396-4B17-971C-5CF585DED14BQ39578385-721A0F92-FFB4-4859-A545-6569EF5FEFBDQ39683238-E149DA9D-3380-4818-A3FF-ED6D07F441D6Q39843165-8CCB4F71-AE2C-4D3F-A842-F31B3403907BQ39879855-81333A00-F1E2-4CD7-96FF-F3015D7C7957Q39996496-3329BF2F-ADFC-403E-BC9B-987060F0D1E6Q40062231-149E9B40-4717-4BB3-A8CB-AD80A416F52FQ40468614-46028FF4-12DF-40EE-A629-6EB53A11F58DQ41120357-E1CE3299-BAC2-4824-816E-51E63F903AA1Q42107901-868073CC-01BA-4BE7-B3F3-E34D088CD27C
P2860
Incorporation of excess wild-type and mutant tRNA(3Lys) into human immunodeficiency virus type 1.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Incorporation of excess wild-t ...... immunodeficiency virus type 1.
@ast
Incorporation of excess wild-t ...... immunodeficiency virus type 1.
@en
type
label
Incorporation of excess wild-t ...... immunodeficiency virus type 1.
@ast
Incorporation of excess wild-t ...... immunodeficiency virus type 1.
@en
prefLabel
Incorporation of excess wild-t ...... immunodeficiency virus type 1.
@ast
Incorporation of excess wild-t ...... immunodeficiency virus type 1.
@en
P2093
P2860
P1433
P1476
Incorporation of excess wild-t ...... immunodeficiency virus type 1
@en
P2093
P2860
P304
P407
P50
P577
1994-12-01T00:00:00Z